0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Activated Carbon Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-9E14215
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Activated Carbon Market Research Report 2023
BUY CHAPTERS

Global Pharmaceutical Activated Carbon Market Research Report 2025

Code: QYRE-Auto-9E14215
Report
March 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Activated Carbon Market

The global market for Pharmaceutical Activated Carbon was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Activated charcoal has been used as an oral medicine for a long time, and in the rescue and treatment of patients with acute transoral poisoning, medicinal activated charcoal is one of the important basic rescue measures, which can obviously reduce the absorption of poison and increase the excretion and removal of poison, and obviously improve the success rate of rescue of patients with transoral poisoning. Oral administration of activated carbon is an effective method to reduce the absorption of poisons taken by patients. As an excellent adsorbent material, activated carbon is not only used for oral adsorption and detoxification in emergency medicine, but also widely used as a blood perfusion adsorbent for artificial organ adsorption preparations, for specific central nervous system, for treating certain previously incurable diseases, and in recent years it has also been used as a drug carrier for solutes, for treating malignant tumors Lymph nodes, for guiding the removal of metastatic lymph nodes, and for adjust the pore size of activated carbon and its distribution so that it can absorb various harmful substances and bacteria.
Units: The units in this report refer to the basic quantity units of statistics, such as tablets (Changtian Pharmaceuticals) for the tablet type, and capsules and pills for the pill type, such as Wuxi Ji Yu Shanhe Pharmaceuticals. The unit of product for bag type or granule type is bag.
The key manufacturers of pharmaceutical activated carbon in the Chinese market are Jemincare, Changtian Pharma, Kureha, Myvitamins, etc. The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%. Production areas are mainly located in Europe, China, Japan, etc. In terms of product type, activated carbon tablets/granules occupy the major market share, accounting for 90%, followed by activated carbon capsules, accounting for about 10%. In terms of application, the pharmacy channel is the top application area, accounting for 70% of the total, while the prescription channel accounts for 28%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Activated Carbon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Activated Carbon.
The Pharmaceutical Activated Carbon market size, estimations, and forecasts are provided in terms of output/shipments (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Activated Carbon market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Activated Carbon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation

Scope of Pharmaceutical Activated Carbon Market Report

Report Metric Details
Report Name Pharmaceutical Activated Carbon Market
by Type
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jemincare, Changtian Pharma, Kureha, Myvitamins
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pharmaceutical Activated Carbon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Pharmaceutical Activated Carbon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Pharmaceutical Activated Carbon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

What is the market share of major companies in Pharmaceutical Activated Carbon Market?

Ans: The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%.

Who are the main players in the Pharmaceutical Activated Carbon Market report?

Ans: The main players in the Pharmaceutical Activated Carbon Market are Jemincare, Changtian Pharma, Kureha, Myvitamins

What are the Type segmentation covered in the Pharmaceutical Activated Carbon Market report?

Ans: The Types covered in the Pharmaceutical Activated Carbon Market report are Pharmaceutical Activated Carbon Capsule, Pharmaceutical Activated Carbon Tablet, Others, by Distribution Channel, Drug Stores, Prescription Drug

Recommended Reports

Activated Carbon Types

Medical Applications

Industrial Activated Carbon

1 Pharmaceutical Activated Carbon Market Overview
1.1 Product Definition
1.2 Pharmaceutical Activated Carbon by Type
1.2.1 Global Pharmaceutical Activated Carbon Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Pharmaceutical Activated Carbon Capsule
1.2.3 Pharmaceutical Activated Carbon Tablet
1.2.4 Others
1.3 Pharmaceutical Activated Carbon by Distribution Channel
1.3.1 Global Pharmaceutical Activated Carbon Market Value Growth Rate Analysis by Distribution Channel: 2024 VS 2031
1.3.2 Drug Stores
1.3.3 Prescription Drug
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharmaceutical Activated Carbon Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharmaceutical Activated Carbon Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharmaceutical Activated Carbon Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Activated Carbon Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Activated Carbon Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharmaceutical Activated Carbon, Industry Ranking, 2023 VS 2024
2.4 Global Pharmaceutical Activated Carbon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Activated Carbon Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharmaceutical Activated Carbon, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Activated Carbon, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Activated Carbon, Date of Enter into This Industry
2.9 Pharmaceutical Activated Carbon Market Competitive Situation and Trends
2.9.1 Pharmaceutical Activated Carbon Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Activated Carbon Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Activated Carbon Production by Region
3.1 Global Pharmaceutical Activated Carbon Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharmaceutical Activated Carbon Production Value by Region (2020-2031)
3.2.1 Global Pharmaceutical Activated Carbon Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharmaceutical Activated Carbon by Region (2026-2031)
3.3 Global Pharmaceutical Activated Carbon Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharmaceutical Activated Carbon Production Volume by Region (2020-2031)
3.4.1 Global Pharmaceutical Activated Carbon Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharmaceutical Activated Carbon by Region (2026-2031)
3.5 Global Pharmaceutical Activated Carbon Market Price Analysis by Region (2020-2025)
3.6 Global Pharmaceutical Activated Carbon Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2020-2031)
4 Pharmaceutical Activated Carbon Consumption by Region
4.1 Global Pharmaceutical Activated Carbon Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharmaceutical Activated Carbon Consumption by Region (2020-2031)
4.2.1 Global Pharmaceutical Activated Carbon Consumption by Region (2020-2025)
4.2.2 Global Pharmaceutical Activated Carbon Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharmaceutical Activated Carbon Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharmaceutical Activated Carbon Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Activated Carbon Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharmaceutical Activated Carbon Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Activated Carbon Production by Type (2020-2031)
5.1.1 Global Pharmaceutical Activated Carbon Production by Type (2020-2025)
5.1.2 Global Pharmaceutical Activated Carbon Production by Type (2026-2031)
5.1.3 Global Pharmaceutical Activated Carbon Production Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Activated Carbon Production Value by Type (2020-2031)
5.2.1 Global Pharmaceutical Activated Carbon Production Value by Type (2020-2025)
5.2.2 Global Pharmaceutical Activated Carbon Production Value by Type (2026-2031)
5.2.3 Global Pharmaceutical Activated Carbon Production Value Market Share by Type (2020-2031)
5.3 Global Pharmaceutical Activated Carbon Price by Type (2020-2031)
6 Segment by Distribution Channel
6.1 Global Pharmaceutical Activated Carbon Production by Distribution Channel (2020-2031)
6.1.1 Global Pharmaceutical Activated Carbon Production by Distribution Channel (2020-2025)
6.1.2 Global Pharmaceutical Activated Carbon Production by Distribution Channel (2026-2031)
6.1.3 Global Pharmaceutical Activated Carbon Production Market Share by Distribution Channel (2020-2031)
6.2 Global Pharmaceutical Activated Carbon Production Value by Distribution Channel (2020-2031)
6.2.1 Global Pharmaceutical Activated Carbon Production Value by Distribution Channel (2020-2025)
6.2.2 Global Pharmaceutical Activated Carbon Production Value by Distribution Channel (2026-2031)
6.2.3 Global Pharmaceutical Activated Carbon Production Value Market Share by Distribution Channel (2020-2031)
6.3 Global Pharmaceutical Activated Carbon Price by Distribution Channel (2020-2031)
7 Key Companies Profiled
7.1 Jemincare
7.1.1 Jemincare Pharmaceutical Activated Carbon Company Information
7.1.2 Jemincare Pharmaceutical Activated Carbon Product Portfolio
7.1.3 Jemincare Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Jemincare Main Business and Markets Served
7.1.5 Jemincare Recent Developments/Updates
7.2 Changtian Pharma
7.2.1 Changtian Pharma Pharmaceutical Activated Carbon Company Information
7.2.2 Changtian Pharma Pharmaceutical Activated Carbon Product Portfolio
7.2.3 Changtian Pharma Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Changtian Pharma Main Business and Markets Served
7.2.5 Changtian Pharma Recent Developments/Updates
7.3 Kureha
7.3.1 Kureha Pharmaceutical Activated Carbon Company Information
7.3.2 Kureha Pharmaceutical Activated Carbon Product Portfolio
7.3.3 Kureha Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Kureha Main Business and Markets Served
7.3.5 Kureha Recent Developments/Updates
7.4 Myvitamins
7.4.1 Myvitamins Pharmaceutical Activated Carbon Company Information
7.4.2 Myvitamins Pharmaceutical Activated Carbon Product Portfolio
7.4.3 Myvitamins Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Myvitamins Main Business and Markets Served
7.4.5 Myvitamins Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Activated Carbon Industry Chain Analysis
8.2 Pharmaceutical Activated Carbon Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Activated Carbon Production Mode & Process Analysis
8.4 Pharmaceutical Activated Carbon Sales and Marketing
8.4.1 Pharmaceutical Activated Carbon Sales Channels
8.4.2 Pharmaceutical Activated Carbon Distributors
8.5 Pharmaceutical Activated Carbon Customer Analysis
9 Pharmaceutical Activated Carbon Market Dynamics
9.1 Pharmaceutical Activated Carbon Industry Trends
9.2 Pharmaceutical Activated Carbon Market Drivers
9.3 Pharmaceutical Activated Carbon Market Challenges
9.4 Pharmaceutical Activated Carbon Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical Activated Carbon Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Pharmaceutical Activated Carbon Market Value by Distribution Channel, (US$ Million) & (2024 VS 2031)
 Table 3. Global Pharmaceutical Activated Carbon Production Capacity (M Units) by Manufacturers in 2024
 Table 4. Global Pharmaceutical Activated Carbon Production by Manufacturers (2020-2025) & (M Units)
 Table 5. Global Pharmaceutical Activated Carbon Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Pharmaceutical Activated Carbon Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Pharmaceutical Activated Carbon Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Pharmaceutical Activated Carbon, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharmaceutical Activated Carbon as of 2024)
 Table 10. Global Market Pharmaceutical Activated Carbon Average Price by Manufacturers (US$/Unit) & (2020-2025)
 Table 11. Global Key Manufacturers of Pharmaceutical Activated Carbon, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Pharmaceutical Activated Carbon, Product Offered and Application
 Table 13. Global Key Manufacturers of Pharmaceutical Activated Carbon, Date of Enter into This Industry
 Table 14. Global Pharmaceutical Activated Carbon Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pharmaceutical Activated Carbon Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Pharmaceutical Activated Carbon Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Pharmaceutical Activated Carbon Production Value Market Share by Region (2020-2025)
 Table 19. Global Pharmaceutical Activated Carbon Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Pharmaceutical Activated Carbon Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Pharmaceutical Activated Carbon Production Comparison by Region: 2020 VS 2024 VS 2031 (M Units)
 Table 22. Global Pharmaceutical Activated Carbon Production (M Units) by Region (2020-2025)
 Table 23. Global Pharmaceutical Activated Carbon Production Market Share by Region (2020-2025)
 Table 24. Global Pharmaceutical Activated Carbon Production (M Units) Forecast by Region (2026-2031)
 Table 25. Global Pharmaceutical Activated Carbon Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Pharmaceutical Activated Carbon Market Average Price (US$/Unit) by Region (2020-2025)
 Table 27. Global Pharmaceutical Activated Carbon Market Average Price (US$/Unit) by Region (2026-2031)
 Table 28. Global Pharmaceutical Activated Carbon Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Units)
 Table 29. Global Pharmaceutical Activated Carbon Consumption by Region (2020-2025) & (M Units)
 Table 30. Global Pharmaceutical Activated Carbon Consumption Market Share by Region (2020-2025)
 Table 31. Global Pharmaceutical Activated Carbon Forecasted Consumption by Region (2026-2031) & (M Units)
 Table 32. Global Pharmaceutical Activated Carbon Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Units)
 Table 34. North America Pharmaceutical Activated Carbon Consumption by Country (2020-2025) & (M Units)
 Table 35. North America Pharmaceutical Activated Carbon Consumption by Country (2026-2031) & (M Units)
 Table 36. Europe Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Units)
 Table 37. Europe Pharmaceutical Activated Carbon Consumption by Country (2020-2025) & (M Units)
 Table 38. Europe Pharmaceutical Activated Carbon Consumption by Country (2026-2031) & (M Units)
 Table 39. Asia Pacific Pharmaceutical Activated Carbon Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (M Units)
 Table 40. Asia Pacific Pharmaceutical Activated Carbon Consumption by Region (2020-2025) & (M Units)
 Table 41. Asia Pacific Pharmaceutical Activated Carbon Consumption by Region (2026-2031) & (M Units)
 Table 42. Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (M Units)
 Table 43. Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption by Country (2020-2025) & (M Units)
 Table 44. Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption by Country (2026-2031) & (M Units)
 Table 45. Global Pharmaceutical Activated Carbon Production (M Units) by Type (2020-2025)
 Table 46. Global Pharmaceutical Activated Carbon Production (M Units) by Type (2026-2031)
 Table 47. Global Pharmaceutical Activated Carbon Production Market Share by Type (2020-2025)
 Table 48. Global Pharmaceutical Activated Carbon Production Market Share by Type (2026-2031)
 Table 49. Global Pharmaceutical Activated Carbon Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Pharmaceutical Activated Carbon Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Pharmaceutical Activated Carbon Production Value Market Share by Type (2020-2025)
 Table 52. Global Pharmaceutical Activated Carbon Production Value Market Share by Type (2026-2031)
 Table 53. Global Pharmaceutical Activated Carbon Price (US$/Unit) by Type (2020-2025)
 Table 54. Global Pharmaceutical Activated Carbon Price (US$/Unit) by Type (2026-2031)
 Table 55. Global Pharmaceutical Activated Carbon Production (M Units) by Distribution Channel (2020-2025)
 Table 56. Global Pharmaceutical Activated Carbon Production (M Units) by Distribution Channel (2026-2031)
 Table 57. Global Pharmaceutical Activated Carbon Production Market Share by Distribution Channel (2020-2025)
 Table 58. Global Pharmaceutical Activated Carbon Production Market Share by Distribution Channel (2026-2031)
 Table 59. Global Pharmaceutical Activated Carbon Production Value (US$ Million) by Distribution Channel (2020-2025)
 Table 60. Global Pharmaceutical Activated Carbon Production Value (US$ Million) by Distribution Channel (2026-2031)
 Table 61. Global Pharmaceutical Activated Carbon Production Value Market Share by Distribution Channel (2020-2025)
 Table 62. Global Pharmaceutical Activated Carbon Production Value Market Share by Distribution Channel (2026-2031)
 Table 63. Global Pharmaceutical Activated Carbon Price (US$/Unit) by Distribution Channel (2020-2025)
 Table 64. Global Pharmaceutical Activated Carbon Price (US$/Unit) by Distribution Channel (2026-2031)
 Table 65. Jemincare Pharmaceutical Activated Carbon Company Information
 Table 66. Jemincare Pharmaceutical Activated Carbon Specification and Application
 Table 67. Jemincare Pharmaceutical Activated Carbon Production (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 68. Jemincare Main Business and Markets Served
 Table 69. Jemincare Recent Developments/Updates
 Table 70. Changtian Pharma Pharmaceutical Activated Carbon Company Information
 Table 71. Changtian Pharma Pharmaceutical Activated Carbon Specification and Application
 Table 72. Changtian Pharma Pharmaceutical Activated Carbon Production (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Changtian Pharma Main Business and Markets Served
 Table 74. Changtian Pharma Recent Developments/Updates
 Table 75. Kureha Pharmaceutical Activated Carbon Company Information
 Table 76. Kureha Pharmaceutical Activated Carbon Specification and Application
 Table 77. Kureha Pharmaceutical Activated Carbon Production (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Kureha Main Business and Markets Served
 Table 79. Kureha Recent Developments/Updates
 Table 80. Myvitamins Pharmaceutical Activated Carbon Company Information
 Table 81. Myvitamins Pharmaceutical Activated Carbon Specification and Application
 Table 82. Myvitamins Pharmaceutical Activated Carbon Production (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Myvitamins Main Business and Markets Served
 Table 84. Myvitamins Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Pharmaceutical Activated Carbon Distributors List
 Table 88. Pharmaceutical Activated Carbon Customers List
 Table 89. Pharmaceutical Activated Carbon Market Trends
 Table 90. Pharmaceutical Activated Carbon Market Drivers
 Table 91. Pharmaceutical Activated Carbon Market Challenges
 Table 92. Pharmaceutical Activated Carbon Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pharmaceutical Activated Carbon
 Figure 2. Global Pharmaceutical Activated Carbon Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Pharmaceutical Activated Carbon Market Share by Type: 2024 VS 2031
 Figure 4. Pharmaceutical Activated Carbon Capsule Product Picture
 Figure 5. Pharmaceutical Activated Carbon Tablet Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Pharmaceutical Activated Carbon Market Value by Distribution Channel, (US$ Million) & (2020-2031)
 Figure 8. Global Pharmaceutical Activated Carbon Market Share by Distribution Channel: 2024 VS 2031
 Figure 9. Drug Stores
 Figure 10. Prescription Drug
 Figure 11. Global Pharmaceutical Activated Carbon Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pharmaceutical Activated Carbon Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Pharmaceutical Activated Carbon Production Capacity (M Units) & (2020-2031)
 Figure 14. Global Pharmaceutical Activated Carbon Production (M Units) & (2020-2031)
 Figure 15. Global Pharmaceutical Activated Carbon Average Price (US$/Unit) & (2020-2031)
 Figure 16. Pharmaceutical Activated Carbon Report Years Considered
 Figure 17. Pharmaceutical Activated Carbon Production Share by Manufacturers in 2024
 Figure 18. Global Pharmaceutical Activated Carbon Production Value Share by Manufacturers (2024)
 Figure 19. Pharmaceutical Activated Carbon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Activated Carbon Revenue in 2024
 Figure 21. Global Pharmaceutical Activated Carbon Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Pharmaceutical Activated Carbon Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Pharmaceutical Activated Carbon Production Comparison by Region: 2020 VS 2024 VS 2031 (M Units)
 Figure 24. Global Pharmaceutical Activated Carbon Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Pharmaceutical Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe Pharmaceutical Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China Pharmaceutical Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Japan Pharmaceutical Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Global Pharmaceutical Activated Carbon Consumption by Region: 2020 VS 2024 VS 2031 (M Units)
 Figure 30. Global Pharmaceutical Activated Carbon Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 32. North America Pharmaceutical Activated Carbon Consumption Market Share by Country (2020-2031)
 Figure 33. U.S. Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 34. Canada Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 35. Europe Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 36. Europe Pharmaceutical Activated Carbon Consumption Market Share by Country (2020-2031)
 Figure 37. Germany Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 38. France Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 39. U.K. Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 40. Italy Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 41. Russia Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 42. Asia Pacific Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 43. Asia Pacific Pharmaceutical Activated Carbon Consumption Market Share by Region (2020-2031)
 Figure 44. China Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 45. Japan Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 46. South Korea Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 47. China Taiwan Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 48. Southeast Asia Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 49. India Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 50. Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 51. Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption Market Share by Country (2020-2031)
 Figure 52. Mexico Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 53. Brazil Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 54. Turkey Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 55. GCC Countries Pharmaceutical Activated Carbon Consumption and Growth Rate (2020-2031) & (M Units)
 Figure 56. Global Production Market Share of Pharmaceutical Activated Carbon by Type (2020-2031)
 Figure 57. Global Production Value Market Share of Pharmaceutical Activated Carbon by Type (2020-2031)
 Figure 58. Global Pharmaceutical Activated Carbon Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Production Market Share of Pharmaceutical Activated Carbon by Distribution Channel (2020-2031)
 Figure 60. Global Production Value Market Share of Pharmaceutical Activated Carbon by Distribution Channel (2020-2031)
 Figure 61. Global Pharmaceutical Activated Carbon Price (US$/Unit) by Distribution Channel (2020-2031)
 Figure 62. Pharmaceutical Activated Carbon Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture